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INTRODUCTION
Spinocerebellar ataxia type 3 (SCA3),
also known as Machado-Joseph disease,
is a rare progressive neurodegenerative
disease and the most common domi-
nantly inherited ataxia worldwide. SCA3
is a polyglutamine (polyQ) disorder
caused by a CAG-trinucleotide repeat ex-
pansion encoding glutamine within the
sequence of the ataxin-3 (ATXN3) gene.
The length of the repeat expansion is di-
rectly related to the aggregation propen-
sity of the ataxin3 protein and is in-
versely related to the age of onset of the
disease. Protein aggregates are consid-
ered to be the cause for neuronal dys-
function and death, which is supported
by several lines of evidence showing that
aggregate prevention or increased (au-
tophagic) clearance delays neuronal
death and degeneration in multiple
model systems (1–4).
The pathophysiological sequel of neu-
rodegeneration in SCA3 is not fully un-
derstood, although proteotoxic stress,
transcriptional dysregulation, mitochon-
drial dysfunction, oxidative stress and
inflammation have been implicated
(5–7). To date, there are no disease-modi-
fying treatments for polyQ diseases such
as SCA3.
Cystathionine γ-lyase (CSE) is one of
the central enzymes in cysteine and hy-
drogen sulfide metabolism (H2S). Homo-
cysteine is a substrate for CSE leading to
the production of H2S, α-ketobutyrate,
ammonia, homolanthionine and cys-
tathionine, with the latter serving as a
CSE substrate to produce cysteine (8,9).
Cysteine is also a substrate for CSE lead-
ing to the production of H2S, cystathion-
ine and pyruvate (8,9). H2S and CSE are
linked to aging and age-related patholo-
gies (10–13). H2S can act as an endoge-
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nous modulator of oxidative stress either
by direct scavenging of reactive oxygen
species (ROS) and nitrogen species (14) or
through increasing the intracellular glu-
tathione (GSH) pool (15,16). H2S also con-
fers cytoprotection via suppression of in-
flammation (17) and by protecting
mitochondrial function and integrity
(17,18). Decreased levels of H2S in brain
tissue are associated with neurodegenera-
tive age-related diseases such as Parkin-
son’s (19), and administration of H2S has
been shown protective in experimental
models for this disease (20–22). Decreased
levels of CSE have recently been observed
in human Huntington disease tissues and
in a mouse Huntington model (22). After
addition of sodium hydrogen sulfide and
L-cysteine, levels of protein persulfidation
(also called protein S-sulfhydration) in-
creased in a CSE-dependent manner in
vitro (23), suggesting an influential effect
of this type of posttranslational protein
modification. Indeed, protein persulfida-
tion has been demonstrated to mediate
the activity of parkin, to serve as an anti-
oxidant and to protect against cellular
senescence (24–26). A possible link be-
tween SCA3, CSE and protein persulfida-
tion remains to be determined as well as
the potential neuroprotective effects of
overexpressing the CSE enzyme directly in
a neurodegenerative background.
Here, we investigated the possible pro-
tective role of CSE in a Drosophila model
for SCA3. Drosophila was chosen because
CSE is highly conserved between humans
and flies (http://flybase.org/blast), and
an established Drosophila model for
SCA3 is available (27,28). In the fly
model for SCA3, a truncated version of
the pathogenic human ATXN3 gene con-
taining a multiple CAG repeat is ex-
pressed, and key features of SCA3 dis-
ease are present (27–29). This model is
suitable because the CAG repeat, and
not the mutated protein, is considered to
be the disease-causing entity in SCA3
and in several other polyQ diseases as
well (29,30). We used the Drosophila
SCA3 model (also called SCA3 flies) to
investigate the effects of CSE overex-
pression. We identified additional phe-
notypes in the SCA3 model, such as loss
of tissue integrity in degenerative
patches in the fly eye, increased activa-
tion of the innate immune response and
decreased protein persulfidation. We
found that transgene-mediated increased
expression of CSE rescues these novel
and also previously reported pheno-
types of the fly SCA3 model. Rescue was
also observed after addition of sodium
thiosulfate, a drug approved by the U.S.
Food and Drug Administration and a
component of the transsulfuration path-
way in which CSE plays a central role
(9,31). The CSE-mediated rescue occurs
independently of protein aggregate for-
mation, indicating that rescue effects
occur downstream of the formation of
these toxic entities. We also found en-
dogenous expression of CSE in brain
areas that are affected in SCA3 patients.
In addition a lower expression was ob-
served in patient samples compared
with controls. We present and discuss a
possible role for CSE in polyQ disease
pathology and treatment.
MATERIALS AND METHODS
Below we provide a brief overview of
the methods used for experiments pre-
sented in this article. For further details,
please see the Supplementary Materials
and Methods.
Drosophila Stocks
As wild-type control, the y1w1118
Drosophila line was used. Eip55E
(Drosophila CSE)-overexpressing lines
were generated in the laboratory. The
GMR-GAL4 UAS-SCA3trQ78 fly stock
was a gift from Nancy M Bonini (28,32).
The detailed description of the Drosophila
lines and fly food, backcrossing and sup-
plementation of chemical compound in-
formation can be found in the Supple-
mentary Materials and Methods.
Eye Degeneration Assay
To evaluate relative degeneration per-
centage, we used an eye scoring method
that was previously described (33,34). Ir-
regularly structured depigmented eyes
without dark patches were defined as
rough. The presence of one or more black
patches along with the irregular struc-
ture and depigmentation was considered
a degenerated rough eye. Each eye of
1-d-old flies was scored as a singular en-
tity. We scored the total amount of de-
generated eyes as opposed to the total
amount of eyes (rough + degenerated).
Total count of eyes scored per condition
was between 100 and 1,000, depending
on the number of progeny of a particular
genotype.
Protein Persulfidation Assay
To detect protein persulfidation, a tag-
switch assay was used as previously de-
scribed (35,36). Briefly, protein extracts
were prepared from either whole flies
(three flies per sample, 100 μL extraction
buffer) for persulfidation analysis of CSE
overexpression effect under control of
actin driver in a nondisease background
or fly heads (25 heads per sample, 65 μL
of extraction buffer) for persulfidation
analysis of CSE overexpression effect
under control of a glass multiple reporter
(GMR) driver in the SCA3 background.
Extracts were prepared using HEN buffer
(50 mmol/L N-2-hydroxyethylpiperazine-
N′-2-ethanesulfonic acid [HEPES],
2 mmol/L ethylenediaminetetraacetic
acid [EDTA], 1 % NP-40) additionally
supplemented with 2% sodium dodecyl
sulfate (SDS), 1% protease inhibitors and
20 mmol/L 2-benzo[d]thiazol-2-
 ylsulfonyl)acetic acid (MSBTA), a water-
soluble methylsulfonyl benzothiazole de-
rivate (37). The extracts were incubated
for 30 min on ice and 30 min at 37°C. Pro-
teins were then purified by using
water/methanol/ chloroform precipitation
(4/4/1, v/v/v). Samples were redis-
solved in phosphate-buffered saline con-
taining 2% SDS and treated with CN-
 biotin (Supplementary Figure S4A, D)
overnight. Protein concentrations were
adjusted to the same value before the SDS
electrophoresis was performed. Biotinyla-
tion of the samples was detected by West-
ern blot, using anti- biotin antibodies
(Sigma-Aldrich). To improve the assay, we
used a new probe, CN-Cy3, which served
as an alternative for CN-biotin and al-
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lowed direct in-gel fluorescence measure-
ments. CN-Cy3 is a cyanoacetate deriva-
tive of a cyanine-based Cy3 fluorescence
dye. (See Figure 1).
Molecular Biology Techniques
For a detailed description of quantita-
tive reverse transcriptase–polymerase
chain reaction (qRT-PCR), Western blot
and protein oxidation analyses, and im-
munohistochemistry used in the current
study, please see the Supplementary Ma-
terials and Methods.
All supplementary materials are available
online at www.molmed.org.
RESULTS
SCA3 Flies Show Increased Tissue
Degeneration
A Drosophila model was used to fur-
ther investigate a possible protective role
of overexpression of CSE in SCA3. First,
we performed an extended phenotypic
analysis of this model. Previously, it was
shown that flies bearing UAS-
SCA3trQ78—an inducible truncated ver-
sion of the human ATXN3 gene contain-
ing 78 CAG repeats—under the control
of the GMR driver (also called GMR-
GAL4-UAS-SCA3trQ78 or SCA3 flies) de-
velop progressive cellular eye degenera-
tion. These flies develop a fully
penetrant “rough eye” phenotype, and a
certain percentage of the rough-eyed flies
possess a variable amount of patches
with increased degeneration in these
rough eyes (27,28). Rough eyes contain-
ing these degenerative patches (further
called “degenerated rough eyes”) are
considered to be more affected compared
with the rough eyes without these
patches; therefore, this is a useful tool to
identify enhancers or suppressors of the
SCA3-induced toxicity (32). To visualize
these phenotypic differences at a higher
magnification and to evaluate the sever-
ity of the rough versus degenerated
rough eye phenotypes in more detail, we
performed correlative light microscopy
and scanning electron microscopy on the
eyes of wild-type flies (Figure 2A–A’’)
and flies overexpressing human ATXN3
(Figures 2B, C). It appeared that the
rough eyes consist of irregular-shaped
ommatidia with irregularly arranged
bristles (Figures 2B–B’’). In contrast, the
degenerative patches contained an unde-
fined structure, and bristles were absent
(Figures 2C–C’’). These results confirmed
that degenerative patches can indeed be
classified as more severely affected tissue
parts compared with the rest of the
rough eye structures. Therefore, an inter-
vention that causes a decreased amount
of rough eyes with degenerative areas
within the SCA3 background can be clas-
sified as protective.
Generation and Characterization of
Various CSE Transgenic Lines
To further investigate a possible mod-
ulating role of CSE in SCA3 pathogene-
sis, we investigated the effect of CSE
overexpression in the SCA3 fly model.
Six different fly lines overexpressing
Eip55E, a highly conserved Drosophila or-
tholog of the human CSE gene
(http://flybase.org/blast) (38) under a
GAL4-inducible promoter, were created.
Because of the absence of an antibody
against Drosophila CSE, the characteriza-
tion of the lines was performed by using
qRT-PCR analysis. CSE expression levels
of each inducible line were determined
in the presence of a daughterless driver,
resulting in ubiquitous expression of the
construct. All six lines showed increased
mRNA expression of CSE compared with
the in-house control w1118 strain (Supple-
mentary Figure S1A). Because the genetic
background of Drosophila plays an im-
portant role in the severity of specific
phenotypes (39), all transgenic overex-
pressing lines were backcrossed for at
least six generations to create isogenic
controls. This step resulted in the genera-
tion of CSE overexpressing strain 1
(called CSE1) and its specific isogenic
control (called control 1) and to the gen-
eration of CSE-expressing strain 2 and 3
(called CSE2 and CSE3) and their iso-
genic control (called control 2). This ap-
proach allowed us to compare the effect
of CSE overexpression in two genetic
backgrounds, to investigate the effect of
variations in overexpression levels and to
compare this to isogenic controls. By
using qRT-PCR, we demonstrated that
CSE1 showed a 2.1-fold induction of CSE
compared with its isogenic control and
that CSE2 and CSE3 showed a 2.2- and
5.3-fold increased expression of CSE
compared with their isogenic control, re-
spectively (Figures 3A, B). Extensive de-
scription of all used Drosophila genotypes
is presented in the Supplementary Mate-
rials and Methods and Supplementary
Figures S1A, B).
Overexpression of CSE Partially
Rescues the Phenotype of SCA3 in
Drosophila
To investigate a possible effect of CSE
overexpression on the eye phenotype, we
scored the percentage of degenerated
eyes (i.e., when degenerated patches vi-
sualized in Figures 2C–C’’ are present) 
1 d after eclosion by using light mi-
croscopy. In the SCA3 background, CSE-
overexpressing flies showed a significant
decrease in the percentage of degenera-
tive rough eyes (Figures 3C, D). Suppres-
sion of the SCA3-degenerative rough eye
Figure 1. Synthesis of Cy3-CN from a commercial Cy3-NHS ester. TEA, triethylamine; DMF,
dimethylformamide.
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phenotype was observed in all CSE-
 overexpressing lines compared with their
SCA3-expressing isogenic control lines.
Similar results were obtained in both ge-
netic backgrounds. The CSE3 line with
the highest level of CSE overexpression
reduced the number of degenerative eyes
to a greater extent than the CSE2 line
(Figure 3D). To further strengthen the
rescue potential of CSE, we pharmaco-
logically inhibited CSE with propargyl-
glycine (PPG) as previously described
(10). Supplementation of PPG to the fly
food reversed the protective effect of CSE
overexpression in the SCA3 background,
as evidenced by an increased percentage
of degenerated rough eyes (Figures 3C, D).
Addition of PPG neither enhanced nor
suppressed the percentage of degenera-
tive eyes in the SCA3 background,
strongly suggesting that the observed ef-
fect in the CSE-overexpressing back-
ground is due to inhibition of CSE and
not due to other effects of PPG. Together,
these results indicate that the rescuing
potential is mediated by overexpression
of CSE and is not influenced by the ge-
netic background.
Overexpression of CSE Does Not
Induce a Change in Levels of
Insoluble Proteins
Polyglutamine diseases are thought to
be driven by protein aggregation that
subsequently triggers a myriad of down-
stream consequences ultimately leading
to neurodegeneration. We thus first tested
whether the rescue of SCA3-induced tis-
sue degeneration by CSE overexpression
was associated with reduced aggregation
of the truncated human ATXN3 protein.
Hereto, we determined ratios of insoluble
versus soluble fractions of ATXN3 pro-
teins in SCA3 flies in the absence and
presence of CSE overexpression by using
Western blot analysis as described previ-
ously (29). An increased insoluble/soluble
ratio indicates an increase in protein ag-
gregation. Overexpression of CSE did
not significantly alter the insoluble/
 soluble ratio in SCA3-expressing flies
(Figures 4A, B; Supplementary Figure S2),
indicating that the protective effects of
CSE overexpression are not mediated by
decreased toxic protein aggregates and
most likely work protectively against
damaging effects downstream of the for-
mation of aggregates.
Overexpression of CSE Reduces
Levels of Oxidative Damage of
Proteins in SCA3 Flies
Oxidative stress is associated with the
pathogenesis of SCA3 disease (40,41).
Previously, it was demonstrated that CSE
deficiency is linked to increased levels of
oxidative stress (42). As a readout for ox-
idative stress, we used OxyBlot analysis
as previously described (43). SCA3 flies
showed increased levels of oxidized pro-
teins (characteristically visible as multiple
bands) compared with their isogenic non-
SCA3 control lines (Figures 4C, D). The
level of oxidized proteins was reduced in
all three CSE overexpression lines in the
SCA3 background compared with the
isogenic controls (Figures 4C, D).
Overexpression of CSE Prevents SCA3-
Associated Immune Induction
Several findings suggest that inflam-
mation contributes to the multifaceted
Figure 2. Increased tissue degeneration is present in neurodegenerative patches within the
rough eye background of SCA3 flies. Eyes of SCA3 and control flies were visualized in detail
using light end electron microscopy. Representative light microscopy pictures (A, B, C) with
correlative scanning electron microscopy pictures (A’, A,” B’, B,” C’, C”) of eye phenotypes
are shown. (A, A’, A’’) Normal control eye phenotype (B, B’, B”) SCA3-overexpressing eye
with a phenotype classified as rough. (C, C’, C”) SCA3-overexpressing eye with a pheno-
type classified as degenerated; black patches show less preservation of tissue integrity.
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pathogenesis of SCA3 disease (44). In
Drosophila, the Toll and immune defi-
ciency (IMD) immune signaling path-
ways mediate activation of nuclear factor
(NF)-κB transcription factors Dif-Dorsal
and Relish, respectively. Targets of these
transcription factors include antimicro-
bial peptides (AMPs). These immune
pathways are equivalent to NF-κB signal-
ing in mammals and are a key factor in
the induction of the innate immune re-
sponse (45). Immune induction by ex-
pression of SCA3trQ78 in Drosophila has
been previously reported as well (46). To
investigate whether CSE-mediated pro-
tection against SCA3 is associated with a
reduction in the immune response, we
performed a qRT-PCR analysis for AMPs,
which are targets of either the IMD or the
Toll pathway. As targets of the Toll path-
way, immune-induced molecule 1 (IM1), im-
mune-induced molecule 2 (IM2) and dro-
somycin were analyzed (47,48), and for
the IMD pathway, attacin, cecropin A1 and
diptericin (45). Expression of SCA3 acti-
vated the immune response of both path-
ways. CSE overexpression in the SCA3
background significantly attenuated all
investigated players of the Toll pathway
(Figure 5). A comparable effect was seen
for a subset of AMPs of the IMD pathway
(Supplementary Figure S3). This result
shows that the suppressive effect of CSE
overexpression on eye degeneration in
SCA3 flies is associated with a dampen-
ing of the Toll pathway and a partial
dampening of the IMD innate immune
response pathway. These data suggest
that CSE may exert its beneficial effects
on the SCA3 phenotype by attenuating
the immune response.
SCA3 Flies Show Reduced Levels of
Protein Persulfidation
Decreased levels of CSE are associated
with impaired neurological function (22).
Here we demonstrated that increased
levels of CSE are protective. Because CSE
overexpression is associated with in-
creased protein persulfidation (25,49), we
hypothesized that, in a SCA3 back-
ground, protein persulfidation may be
decreased and CSE overexpression may
Figure 3. CSE overexpression suppresses the SCA3 phenotype. (A, B) CSE overexpression
was determined by using qRT-PCR in CSE (CSE1; CSE2; CSE3) overexpressing transgenic fly
lines compared with their isogenic controls (control 1 and control 2). CSE was expressed
ubiquitously by using an actin-GAL4 driver. In both genetic backgrounds, CSE mRNA levels
were increased in the CSE-overexpressing lines compared with their isogenic controls. 
*p < 0.05, error bars indicate standard error of the mean (SEM). (C, D) SCA3 flies with and
without overexpression of CSE (three independent lines) were analyzed. In all three trans-
genic lines in the SCA3 background, CSE overexpression resulted in a decrease of the de-
gree of eye degeneration compared with isogenic SCA3-expressing lines. Inhibition of CSE
by 2 mmol/L PPG diminished this effect. The presence of degenerative patches (black
area) was determined by using light microscopy. For quantification, the number of rough
and degenerated eyes in at least three independent experiments (n = 100–300 per ex-
periment) was counted. ***p < 0.001, error bars indicate SEM. Black area represents the
percentage of rough eyes containing neurodegenerative patches. Grey area represents
percentage of rough eyes without neurodegenerative patches.
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lead to restoration of this posttransla-
tional modification.
To selectively detect protein persulfi-
dation, a recently reported tag-switch
assay was further optimized and used.
The original method labels the persulfi-
dation of proteins with biotin as a re-
porting tag (Supplementary Figures
S4A–C). To further enhance the signal
intensity, the tag-switch assay was im-
proved by using a reagent, which di-
rectly introduced a cyanine-based Cy3
fluorescence tag, Cy3-CN (Supplemen-
tary Figure S4A), to persulfidated pro-
teins. An artificial color scheme was
used to better illustrate the persulfida-
tion levels (the color scale is given in the
figure). A signal in the yellow-white
range indicates high levels of persulfida-
tion, and a signal in the black-blue range
indicates a low level (see also the Sup-
plemental Data). Persulfidation of pro-
teins in heads of SCA3 flies was found
to be decreased compared with wild-
type controls (Figure 6A). Next, we in-
vestigated whether the protective effect
of CSE overexpression was associated
with restoration of protein persulfida-
tion. Consistently with our hypothesis,
we found that CSE- overexpressing flies
demonstrated elevated protein persulfi-
dation compared with the controls (Fig-
ure 6B, Supplementary Figure S4D). The
observed rescue of SCA3 degeneration
in CSE- overexpressing fly lines was as-
sociated with normalization of protein
persulfidation levels (Figure 6C, Supple-
mentary Figures S4B, C). These data
showed that degenerative defects of
SCA3 are associated with decreased lev-
els of protein persulfidation, and this
can be reversed by overexpression of
CSE, an intervention that also protects
against tissue loss in the Drosophila
SCA3 model.
Treatment with Sodium Thiosulfate
Reduces Eye Degeneration in SCA3
Flies
To try to pharmacologically rescue
SCA3-induced degeneration, we used
sodium thiosulfate (STS). STS is a rela-
tively stable nontoxic compound used in
Figure 4. SCA3tr-Q78 protein expression and aggregation is not altered, and oxidative stress
is reduced in the presence of CSE overexpression. (A) Western blot analysis of extracts of
heads of SCA3-overexpressing flies was used to determine levels of protein aggregation.
The samples were analyzed for the amount of soluble SCA3tr-78 protein (present in resolving
gel) and levels of SCA3tr-78 protein aggregation (present in stacking gel) by using an anti-
HA antibody. α-Tubulin was used as a loading control. In the SCA3 flies, both soluble
monomer (in the resolving gel) and aggregated protein (in the stacking gel) fractions were
detected. CSE overexpression did not significantly alter the solubility of the SCA3 protein. (B)
Quantification of the ratio between the relative intensity of the protein band in the stacking
gel and SCA3tr-78 monomer band in the resolving gel. There was no significant change in
the protein solubility upon the overexpression of CSE in a SCA3 background (n = 5). (C, D)
OxyBlot analysis of extracts derived from fly heads was used to examine levels of oxidized
proteins. SCA3 flies had higher total levels of oxidized proteins compared with wild-type flies.
CSE overexpression in the SCA3 background showed a reduction of oxidized proteins. Three
independent CSE-overexpressing lines were used and compared with their isogenic con-
trols. For quantification, optical density of oxidized proteins was normalized to tubulin; levels
of oxidized proteins in CSE-overexpressing SCA3 fly samples were comparable to levels in
control fly heads. *p < 0.05, **p < 0.01, error bars indicate SEM.
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clinical settings to treat caliciphylaxis, ex-
travasations during chemotherapy or
cyanide poisoning (50), and is also a
component of the transsulfuration path-
way. Used as a substrate for rhodanase-
like enzymes, thiosulfate could also be a
source of targeted persulfidation, as re-
cently proposed by Mishanina et al. (31).
Therefore, we tested the effects of thio-
sulfate on SCA3 flies.
Increasing concentrations of STS were
fed to SCA3-expressing flies to investi-
gate possible toxicity of STS. Concentra-
tions of ≥120 mmol/L STS induced
lethality (data not shown). Upon supple-
mentation of lower concentrations of
STS, a dose-dependent decrease in the
percentage of degenerated rough eyes
was observed (Figure 7A). A total of 
80 mmol/L STS reduced the percentage
of degenerated rough eyes in SCA3-
 overexpressing conditions in two genetic
backgrounds (Figure 7B). These data
show that the suppression of SCA3-
 associated degeneration is achieved not
only using a genetic approach by overex-
pression of CSE but can also be achieved
pharmacologically using STS.
Endogenous CSE Is Present in Affected
Brain Tissue of SCA3 Patients
To investigate a possible role of CSE in
human SCA3 pathogenesis, we investi-
gated the expression levels and localiza-
tion of CSE in healthy tissue and in
SCA3 disease tissue. To determine the
presence and localization of CSE, we per-
formed immunohistochemistry for CSE
on postmortem pontine tissue of control
individuals and SCA3 patients. From the
sparse tissue available for this rare dis-
ease, pontine tissue was chosen to ana-
lyze the features of this disorder, because
in this tissue several types of toxic pro-
tein aggregates are present with enough
neurons preserved to allow immunohis-
tochemical analysis (7) in contrast to
other brain areas that are almost com-
pletely degenerated or that hardly show
degeneration or protein aggregation
(51,52). As control samples, postmortem
tissue of individuals without a neurode-
generative or neuropsychiatric disease
were used (Supplementary Table S1; n =
7). CSE protein expression was observed
in vascular endothelium, neurons and as-
trocytes (Figures 7C–F). This localization
pattern was not affected in pontine tissue
of SCA3 patients (Figures 7G–J; Supple-
mentary Figure S5). To investigate ex-
pression levels of CSE, we performed
qRT-PCR analysis for CSE transcripts on
pontine samples of SCA3 patients and
control samples. qRT-PCR data revealed
the presence mRNA levels of CSE in
pontine tissue of control tissue (n = 7)
and SCA3 (n = 6) patients; although, in
the latter, levels were reduced (Figure 7K).
Western blot analysis using an anti-CSE
antibody (53) further confirmed the pres-
ence and decreased levels of endogenous
CSE in pontine tissue of SCA3 patients
compared with controls (Figures 7L, L’).
Together, these data demonstrated that
CSE is endogenously present but de-
creased expressed in affected brain areas
of SCA3 patients.
DISCUSSION
We present evidence that CSE overex-
pression works protectively in a
Drosophila model for the neurodegenera-
tive disease SCA3. To our knowledge,
protective effects by CSE overexpression
in neurodegenerative animal models have
not been described before. However, neu-
roprotective effects of H2S have been re-
ported previously, not only in experimen-
tal models for Parkinson’s disease, (21),
vascular dementia (54) and homocysteine-
induced neurotoxicity, but also in in vitro
models for oxidative stress in neurons (55)
and Alzheimer’s disease (56). In an exper-
imental mouse model for Parkinson’s dis-
ease, inhalation of H2S prevents the devel-
Figure 5. Overexpression of CSE prevents SCA3-related immune induction. mRNA levels of
various immune response genes (IM1, IM2, Drosomycin) were determined by qRT-PCR in con-
trol flies, in SCA3 flies (2 genetic backgrounds) and in SCA3 flies overexpressing CSE in the
same isogenetic background. In SCA3-expressing flies, all investigated immune players were
upregulated compared with control flies of the same genetic background. In CSE-expressing
flies in various SCA3 backgrounds, immune response gene expression was lower compared
with the isogenetic SCA3 backgrounds. *p < 0.05, **p < 0.01 and ***p < 0.001, error bars indi-
cate SEM. IM 1, immune-induced molecule 1; IM 2, immune-induced molecule 2.
R E S E A R C H  A R T I C L E
M O L  M E D  2 1 : 7 5 8 - 7 6 8 ,  2 0 1 5  |  S N I J D E R  E T  A L .  |  7 6 5
opment of neurodegeneration and move-
ments disorders (20).
The findings in Drosophila may be of
clinical relevance because we observed
that, in SCA3 patients, CSE expression is
decreased in affected brain areas com-
pared with controls. Recently, decreased
levels of CSE were also demonstrated in
striatal brain samples from patients with
Huntington disease (22). CSE–/– mice
showed impaired locomotor functions
(22); therefore, it is possible that low lev-
els of CSE negatively influence the pro-
gression of neurodegenerative pheno-
types in Huntington disease and SCA3.
This result is consistent with our findings
showing that, in contrast to decreasing
CSE levels, boosting CSE expression in a
neurodegenerative background is benefi-
cial. In contrast to our results, CSE pro-
tein levels were found unaltered in the
cerebellum and cerebral cortex of one
spinocerebellar ataxia patient (SCA sub-
type unknown) (22), suggesting that al-
teration of CSE levels in SCA patients
may be confined to pontine tissue or
may depend on the SCA subtype.
CSE is an essential enzyme in the
transsulfuration pathway and plays a
role in the endogenous production of cys-
teine (57) and H2S (58–60). Therefore, the
beneficial effects of CSE can be mediated
via cysteine, H2S or both. It is also possi-
ble that the increased expression of CSE
catalyzes the formation of cysteine per-
sulfides that can trans-persulfidate the
proteins without any H2S being produced
(61). The explanation of the beneficial ef-
fects by protein persulfidation is in agree-
ment with our observations that this
posttranslational modification is in-
creased in CSE-overexpressing flies and
restored in CSE-overexpressing flies in a
SCA3 background. Moreover, it also ex-
plains the rescue effect of STS, assuming
that the proposed effect of STS on protein
persulfidation is correct (31). A protective
effect of protein persulfidation has been
demonstrated in other studies as well.
For example, the activity of neuroprotec-
tive ubiquitin ligase parkin is regulated
by protein persulfidation. Parkin persulfi-
dation is markedly depleted in the brains
Figure 6. Protein persulfidation is decreased in SCA3 flies and restored by overexpression of
CSE. (A) Persulfidation levels in the SCA3 fly heads are decreased compared with control flies.
Protein persulfidation was determined using the tag-switch assay with direct fluorescence la-
beling and in-gel fluorescence detection. The gels were artificially colorized in ImageJ for bet-
ter visualization of the changes in the signal intensity. Fluorescence intensity scale is provided
at the right. Silver-stained gels were shown to demonstrate equal protein loading of the sam-
ples. Note that because of the sensitivity of the methods, not all bands visualized by silver
staining will be detected by the fluorescence detection of protein persulfidation and vice
versa. Fluorescence intensity scale is provided; signal in the white-yellow range of colors indi-
cates relatively high levels of protein persulfidation; signal in the black-blue range indicates
relatively low levels of protein persulfidation. Extracts of control flies and SCA3 flies were
loaded. (B) CSE overexpression in wild-type flies elevates levels of persulfidation. Protein persul-
fidation was determined using the tag-switch assay with direct fluorescence labeling and in-
gel fluorescence detection. Extracts of flies overexpressing CSE showed an increase of protein
persulfidation compared with the control flies. (C) Protein persulfidation levels in the SCA3 fly
heads are decreased compared with control flies, and CSE overexpression in the SCA3 back-
ground resulted in the partial restoration of persulfidation levels.
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of patients with Parkinson’s disease (24).
Another study demonstrates that the ca-
pacity of H2S to protect against oxidative
stress is executed via persulfidation
(25,26). These findings together with our
results suggest that boosting the transsul-
furation pathway may contribute to neu-
roprotection via increased persulfidation
of proteins.
Our results show that overexpression
of CSE is associated with a dampening of
the immune response and decreased lev-
els of protein oxidation. This finding is
consistent with previous findings be-
cause inflammation has been implicated
as a critical mechanism responsible for
the progressive nature of neurodegenera-
tion (44,62), and there is an inverse link
between an activated transsulfuration
pathway and the immune response. In
experimental models, H2S exerts anti-
neuroinflammatory effects via inhibition
of p38/Jun nuclear kinase and NF-κB
signaling pathways (63), and the inhibi-
tion of CSE by PPG leads to increased in-
flammation (64). Furthermore, CSE has
been shown to be a modulator of oxida-
tive stress in mice (42). SCA3 is associ-
ated with oxidative stress because mu-
tant ATXN3 is associated with a
significantly reduced capability to coun-
teract oxidative stress that contributes to
neuronal cell death in SCA3 (65).
On the basis of the discussed results of
others and our observations, we propose
the following hypothetical model: PolyQ
diseases lead to accumulation of toxic
protein aggregates, and this somehow
reduces levels of CSE and/or protein
persulfidation. This result, in turn, con-
tributes to increased oxidative stress and
an augmented immune response leading
to accelerated neurodegeneration. It is
possible that overexpression of CSE in-
duces protein persulfidation (via or in-
dependent from induced H2S and/or
cysteine biosynthesis). Increased levels
of protein persulfidation reduces the lev-
els of oxidative stress and dampens the
immune response, and, by this, the dam-
aging effects of toxic protein aggregates
are reduced and tissue integrity is better
preserved.
Figure 7. Treatment with STS suppresses SCA3-associated degeneration in Drosophila, and
CSE levels are decreased in brains of SCA3 patients. (A, B) Effect of the H2S donor sodium
thiosulfate was determined on the degenerative eye phenotype by using light mi-
croscopy. The number of rough and degenerated eyes was counted in three indepen-
dent experiments (n = 100–300 per experiment). (A) Increasing concentrations of STS re-
sulted in a reduced percentage of degenerated rough eyes of SCA3-expressing flies in
the control1 background. (B) Addition of 80 mmol/L STS to the food of SCA3-expressing
lines in two genetic backgrounds partly rescued the SCA3-induced eye degenerative
phenotype. *p < 0.05, error bars indicate SEM. (C–J) Immunohistochemistry by using an
anti-human CSE antibody revealed that in control human pontine tissue (C–F) and in
pontine tissue of SCA3 patients (sample 5, Supplementary Table S1) (representative im-
ages are shown in G–J), CSE is localized in neurons of the pontine nuclei (C, G), the vas-
culature (D, H) and astrocytes (E, I). Black arrows indicate the mentioned structures. No
differences in staining pattern were observed between control and SCA3 brain tissue.
Omission of the primary antibody resulted in absence of staining; representative images
are shown (F, J). Scale bar indicates 150 μm in all images. (K) CSE mRNA levels were deter-
mined by using qRT-PCR (control, n = 7; SCA3, n = 6). (L,L’) CSE protein levels were deter-
mined using Western blot analysis. Control samples correspond with control: 2, 3, 4, 6, re-
spectively (Supplementary Table S1); SCA3 samples correspond with SCA3: 2, 3, 4, 5,
respectively (Supplementary Table S1). *p < 0.05, error bars indicate SEM.
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Our data show that CSE levels are de-
creased in tissue of SCA3 patients. How-
ever, in our opinion, it is more important
that CSE is still expressed in affected tis-
sue and apparently in identical cell
types, because this result allows a strat-
egy to increase CSE expression or activ-
ity by pharmacological inventions to pro-
tect against tissue degeneration in SCA3.
Little is known about the regulation of
CSE, but there are substances available
that are able to influence CSE activity or
transcription. There is evidence that
myeloid zinc finger 1 and specificity pro-
tein 1 transcription factor affect the tran-
scription of CSE (66). Furthermore, stud-
ies suggest that CSE can be upregulated
by bacterial endotoxin (66,67) and by ni-
tric oxide (68). S-adenosylmethionine
and pyridoxal-5′-phosphate stimulate
CSE activity to increase H2S production
(69,70). Alternatively to increasing CSE
expression as a therapeutic option, res-
cue may be provoked by STS because
our data show a protective effect of this
compound as well, and it is tolerated by
humans in high concentrations (71,72).
CONCLUSION
Our data indicate a modifying role of
the transsulfuration pathway in SCA3
and suggest that this is mediated via
protein persulfidation. The presence of
CSE in SCA3-relevant brain regions, to-
gether with the protective effects of CSE
overexpression in Drosophila, indicates
the relevance for future research on de-
veloping clinically applicable activators
of CSE or other members of the transsul-
furation pathway. As the protective ef-
fects occur downstream of the formation
of protein aggregates, it may be possible
that activation of the transsulfuration
pathway is protective for other polyglut-
amine expansion–induced diseases as
well.
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